Published in:
01-11-2006 | Pediatric Original
Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1
Authors:
Alberto Giannini, Anna Maria Pinto, Giordano Rossetti, Edi Prandi, Danilo Tiziano, Christina Brahe, Nardo Nardocci
Published in:
Intensive Care Medicine
|
Issue 11/2006
Login to get access
Abstract
Background
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare autosomal recessive neuromuscular disease of unknown prevalence characterized by degeneration of anterior horn α-motoneurons and manifesting in the first 6 months of life as life-threatening irreversible diaphragmatic paralysis associated with progressive symmetrical muscular weakness (distal lower limbs mainly involved), muscle atrophy, and peripheral sensory neuropathy.
Setting
Pediatric intensive care unit of tertiary care hospital.
Patients
We present two new cases of SMARD1 and report two new mutations in the gene IGHMBP2 which encodes immunoglobulin μ-binding protein 2 on chromosome 11q13.
Conclusions
SMARD1 is a poor-prognosis disease that should be considered when acute respiratory insufficiency, of suspected neuromuscular or unclear cause, develops during the first 6 months of life. Diaphragmatic paralysis, manifesting as dyspnea and paradoxical respiration, is the most prominent presenting sign and diaphragmatic motility should be investigated early by fluoroscopy or ultrasound. Electromyography and nerve conduction studies revealing peripheral motor and sensory neuropathy then suggest the diagnosis which should be confirmed by genetic analysis.